Detalhe da pesquisa
1.
Albumin promotes the progression of fibroblasts through late G1 into S-phase in the absence of growth factors.
Cell Cycle
; 19(17): 2158-2167, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715871
2.
Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition.
PLoS One
; 14(6): e0217399, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158244
3.
A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAFV600E-Mutant Brain Tumor.
Cancer Discov
; 8(9): 1130-1141, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880583
4.
Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.
Cancer Discov
; 7(3): 277-287, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986707
5.
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer.
Cancer Discov
; 5(9): 960-971, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26036643